SUBSCRIBE
SUBSCRIBE
News   Business

Facet Biotech Chief Business Officer “Terminated”

January 7, 2009 | 
1 min read

January 6, 2009 - San Francisco Business Times - Redwood City’s Facet Biotech Corp. — recently spun off from PDL BioPharma Inc. — will part with its chief business officer Friday.

People
MORE ON THIS TOPIC
Pictured: Eli Lilly Campus in San Diego
Drug shortages
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
November 22, 2024
 · 
2 min read
 · 
Tristan Manalac
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & Acquisitions
Novartis CEO Promises More Deals of Up to $5B, With an Eye for Early Science
November 21, 2024
 · 
2 min read
 · 
Annalee Armstrong
Business
51%: The Untapped Market
November 21, 2024
 · 
1 min read
 · 
Lori Ellis
Novartis' office building in Marburg, Germany
Mergers & acquisitions
Novartis Buys Kate Therapeutics, Eyeing $55B CGT Market Opportunity by 2030
November 21, 2024
 · 
2 min read
 · 
Tristan Manalac